162 related articles for article (PubMed ID: 14699150)
1. Accelerated cell cycle progression in osteoblasts overexpressing the c-fos proto-oncogene: induction of cyclin A and enhanced CDK2 activity.
Sunters A; Thomas DP; Yeudall WA; Grigoriadis AE
J Biol Chem; 2004 Mar; 279(11):9882-91. PubMed ID: 14699150
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
3. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes.
Smith E; Redman RA; Logg CR; Coetzee GA; Kasahara N; Frenkel B
J Biol Chem; 2000 Jun; 275(26):19992-20001. PubMed ID: 10867026
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation.
Liu E; Li X; Yan F; Zhao Q; Wu X
J Biol Chem; 2004 Apr; 279(17):17283-8. PubMed ID: 15004027
[TBL] [Abstract][Full Text] [Related]
6. Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells.
Ammanamanchi S; Tillekeratne MP; Ko TC; Brattain MG
Cancer Res; 2004 Apr; 64(7):2509-15. PubMed ID: 15059906
[TBL] [Abstract][Full Text] [Related]
7. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
9. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
Blain SW; Montalvo E; Massagué J
J Biol Chem; 1997 Oct; 272(41):25863-72. PubMed ID: 9325318
[TBL] [Abstract][Full Text] [Related]
10. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
Calbó J; Serna C; Garriga J; Graña X; Mazo A
Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
Keenan SM; Lents NH; Baldassare JJ
J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
13. Unusual regulation of cyclin D1 and cyclin-dependent kinases cdk2 and cdk4 during in vivo mitotic stimulation of olfactory neuron progenitors in adult mouse.
Kastner A; Moyse E; Bauer S; Jourdan F; Brun G
J Neurochem; 2000 Jun; 74(6):2343-9. PubMed ID: 10820194
[TBL] [Abstract][Full Text] [Related]
14. c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1.
Güller M; Toualbi-Abed K; Legrand A; Michel L; Mauviel A; Bernuau D; Daniel F
World J Gastroenterol; 2008 Nov; 14(41):6339-46. PubMed ID: 19009649
[TBL] [Abstract][Full Text] [Related]
15. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
[TBL] [Abstract][Full Text] [Related]
16. RACK1 regulates G1/S progression by suppressing Src kinase activity.
Mamidipudi V; Zhang J; Lee KC; Cartwright CA
Mol Cell Biol; 2004 Aug; 24(15):6788-98. PubMed ID: 15254245
[TBL] [Abstract][Full Text] [Related]
17. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
18. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
19. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
[TBL] [Abstract][Full Text] [Related]
20. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest.
Tamir A; Petrocelli T; Stetler K; Chu W; Howard J; Croix BS; Slingerland J; Ben-David Y
Cell Growth Differ; 2000 May; 11(5):269-77. PubMed ID: 10845428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
